After short-term treatments (6 or 9 h) with UA a strong AKT inhibition with concomitant GSK3β activation and reduced β-catenin levels could be detected in synovial SW982 sarcoma cells (Fig 4). The gene discussed is GSK3B; the disease is sarcoma.